Evolutionary Genomics, Inc. announced that it will receive $1,004,004 in an equity round of funding on March 24, 2022. The minimum investment accepted from any outside investor is $10,000. The securities will be issued pursuant to regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 USD | -25.00% |
|
-.--% | -.--% |
2023 | Evolutionary Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2023 | Evolutionary Genomics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 29.95L | |
+38.36% | 5.25TCr | |
+36.73% | 3.93TCr | |
-8.63% | 3.9TCr | |
+25.46% | 2.82TCr | |
-11.17% | 2.66TCr | |
+11.44% | 2.62TCr | |
+45.09% | 1.42TCr | |
+32.93% | 1.26TCr | |
-5.30% | 1.17TCr |
- Stock Market
- Equities
- FNAM Stock
- News Evolutionary Genomics, Inc.
- Evolutionary Genomics, Inc. announced that it expects to receive $1.004004 million in funding